跳至主要内容
临床试验/NCT05337085
NCT05337085Unknown1 期

To Compare Dexmedetomidine and Midazolam for Intra-op Sedation in TIVA in Children Undergoing Inguinal Hernia Repair

Sheikh Zayed Medical College0 个研究点目标入组 185 人开始时间: 2022年6月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
入组人数
185
主要终点
Level of sedation assessed through Ramsay Sedation Scale RSS

研究概览

简要总结

To compare dexmedetomidine and midazolam for intra-op sedation in TIVA in children undergoing inguinal hernia repair. The results of the study if found significant will guide the anesthetist in appropriate choice and dose of sedative drug with highest efficacy and minimum side effects to avoid post operative adverse effects associated with anesthesia

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Participant)

入排标准

年龄范围
12 Months 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Male and female paediatric patients In age range neonates to 15 years
  • Planned for elective inguinal hernia repair
  • Patients with uncomplicated hernia With ASA class I or II

排除标准

  • Patients undergoing emergency inguinal repair
  • Patients with ASA class III,IV,V or VI
  • Patients present with complicated hernia
  • Patients with BMI above 40kg/m2
  • Patients with any allergy to anesthesia
  • Patients with coagulopathy
  • Patients with narcotic/opioid addiction

研究组 & 干预措施

Dexmedetomidine

Active Comparator

Inj. Dexmedetomidine (precidex) 200/mcg/2ml given to participants in infusion form for 10 mins of surgery and maintenance dose given till the end of surgery

干预措施: Dexmedetomidine (Drug)

Midazolam

Active Comparator

Inj midazolam 0.5 mg/kg stat dose will be given to participants during surgery

干预措施: Midazolam (Drug)

结局指标

主要结局

Level of sedation assessed through Ramsay Sedation Scale RSS

时间窗: 6 months

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Anab Farooqi

Dr. Anab Farooqi

Sheikh Zayed Medical College

相似试验

Comparison of Dexmedetomidine and Midazolam for... | 临床试验